CareTrust REIT (CTRE) and Medical Properties Trust (MPT) on Torvanta's measures: CTRE grades higher on 4 of the 4 factor families and MPT on 0.
| CTRE | MPT | |
|---|---|---|
| Value grade | C | n/a |
| Growth grade | B | n/a |
| Profitability grade | A- | n/a |
| Momentum grade | C+ | F |
| Market value | $8.6B | n/a |
| P/E (trailing) | 22.8x | n/a |
| Forward P/E (Torvanta model estimate) | Subscribers | Subscribers |
| Revenue, last 12 months | $571.4M | n/a |
| Revenue growth (y/y) | +53% | n/a |
| Operating margin | n/a | 0.0% |
| Return on invested capital | n/a | n/a |
| Free-cash-flow yield | 5.2% | 7.6% |
| Total return, 1 year | +12.7% | -38.1% |
| Total return, 3 years | n/a | n/a |
Full CTRE analysis · Full MPT analysis
CareTrust REIT (CTRE) and Medical Properties Trust (MPT) on Torvanta's measures: CTRE grades higher on 4 of the 4 factor families and MPT on 0. Which fits an investor depends on their goals; this is research, not a recommendation. Subscribers see where the model ranks each and its expected return.
On trailing earnings CTRE trades at 22.8x and MPT at n/a; their value grades are C and n/a against their sectors.
Subscribers get a rating, a fair value estimate, a 12-month target and a risk read for every S&P 500 company, Torvanta's earnings estimates, and three model portfolios (Active, Adaptive and Patient) with every trade sized and explained. A free account includes 3 full Stock Analyst reports a month.
See plans Or get the free weekly newsletterTorvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.
All stock ratings · Stock lists · AI stock research · Model portfolio · Research · Disclaimer